Human FGF-3 Antibody, R&D Systems™

FGF-3

Monoclonal

LYOPH

Western Blot 1 ug/mL, Immunohistochemistry 8-25 ug/mL, Neutralization 2-5 ug/mL

P11487

FGF3

E. coli-derived recombinant human FGF-3 Asp28-Arg212 Accession # P11487

25 μg

Primary

Detects human FGF-3 in direct ELISAs and Western blots. In direct ELISAs and Western blots, no cross-reactivity with recombinant human (rh) FGF-4, -5, -6, -7, -9, -10, -11, -12, -16, -17, -18, -19, -20, -21, -23, rhFGF acidic, rhFGF basic, recombinant mouse (rm) FGF-8b, -8c, or -15 is observed.

Human

Purified

Western Blot, Immunohistochemistry, Neutralization

254625

Unconjugated

Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative

FGF3, fibroblast growth factor 3, fibroblast growth factor 3 (murine mammary tumor virus integration site (v-int-2) oncogene homolog), HBGF-3, Hst, INT-2, mouse, oncogene INT2

Mouse

Protein A or G purified from hybridoma culture supernatant

RUO

2248

Reconstitute at 0.5 mg/mL in sterile PBS.

Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.

IgG2a